Fact CheckerSign in

NCT04390009RecruitingEarly phase 1

Entire-body PET Scans for Multiple Sclerosis

Exploratory Study of Entire-body PET Scans for Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 6 Oct 2026

Brief summary (registry, in English)

To evaluate whether an entire-body positron emission tomography (PET) scanner can be exploited to improve evaluation, monitoring and measurement of both peripheral and central demyelination in multiple sclerosis (MS) patients.

Status (registry)
Recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
20 (estimated)
First submitted
12 May 2020
Start date
30 Sept 2024
Primary completion date
30 Dec 2027
Lead sponsor
Brain Health Alliance
NCT number
NCT04390009

What you commit to

  • Study type: Interventional · Early phase 1
  • Planned participants: 20
  • From 30 Sept 2024 to the primary completion date, 30 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any additional complicating medical illness other than MS including any other neuropsychiatric illness unrelated to MS diagnosed prior to the onset of initial symptoms of MS.
  • Any known concomitant acute infection.
  • Recent surgery, chemotherapy or radiation therapy.

Other illness

  • Diabetes or other metabolic-endocrine disorders.
  • History of metastatic or locally invasive cancer.

Other

  • Pregnancy or breast feeding.

Who the study is looking for

  • Multiple sclerosis (MS) patients diagnosed by a credentialed neurologist experienced with care of multiple sclerosis patients.
  • Normal healthy subjects.
  • Willing and able to lie motionless on the PET-CT scanner bed for at least 10 minutes and up to 20 minutes for the duration of the PET-CT medical imaging scan.

Age in the registry: 25 years to 55 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Brain Health Alliance
Coordinator of this site? Confirm its status
Ladera RanchUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.